BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9115622)

  • 1. Toxicology and epidemiology of 1,3-butadiene.
    Himmelstein MW; Acquavella JF; Recio L; Medinsky MA; Bond JA
    Crit Rev Toxicol; 1997 Jan; 27(1):1-108. PubMed ID: 9115622
    [No Abstract]   [Full Text] [Related]  

  • 2. 1,3-Butadiene: exposure estimation, hazard characterization, and exposure-response analysis.
    Hughes K; Meek ME; Walker M; Beauchamp R
    J Toxicol Environ Health B Crit Rev; 2003; 6(1):55-83. PubMed ID: 12587254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a unit risk factor for 1,3-butadiene based on an updated carcinogenic toxicity assessment.
    Grant RL; Haney J; Curry AL; Honeycutt M
    Risk Anal; 2009 Dec; 29(12):1726-42. PubMed ID: 19878488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health risk assessment of 1,3-butadiene as a Priority Substance in Canada.
    Hughes K; Meek ME; Walker M
    Chem Biol Interact; 2001 Jun; 135-136():109-35. PubMed ID: 11397385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Issues for discussion: benzene-induced leukemia--human studies.
    Bayliss D; Sonawane B
    J Toxicol Environ Health A; 2000 Nov; 61(5-6):467-70. PubMed ID: 11086953
    [No Abstract]   [Full Text] [Related]  

  • 6. Petroleum worker studies and benzene risk assessment.
    Schnatter R
    J Toxicol Environ Health A; 2000 Nov; 61(5-6):433-7. PubMed ID: 11086949
    [No Abstract]   [Full Text] [Related]  

  • 7. An evaluation of modeled benzene exposure and dose estimates published in the Chinese-National Cancer Institute collaborative epidemiology studies.
    Budinsky RA; DeMott RP; Wernke MJ; Schell JD
    Regul Toxicol Pharmacol; 1999 Dec; 30(3):244-58. PubMed ID: 10620474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer risk in the work place, including asbestos.
    Nicholson WJ
    Eur J Cancer Prev; 1996 Oct; 5(5):393-6. PubMed ID: 8972272
    [No Abstract]   [Full Text] [Related]  

  • 9. [A simple method for risk assessment and its application to 1,3-butadiene].
    Zocchetti C; Pesatori AC; Bertazzi PA
    Med Lav; 2004; 95(5):392-409. PubMed ID: 15595202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia risk and relevant benzene exposure period-Re: follow-up time on risk estimates, Am J Ind Med 42:481-489, 2002.
    Glass DC; Sim MR; Fritschi L; Gray CN; Jolley DJ; Gibbons C
    Am J Ind Med; 2004 Feb; 45(2):222-3; author reply 224-5. PubMed ID: 14748054
    [No Abstract]   [Full Text] [Related]  

  • 11. Determining the hazards of workplace chemicals.
    Checkoway H
    Epidemiology; 1993 Mar; 4(2):91-2. PubMed ID: 8452912
    [No Abstract]   [Full Text] [Related]  

  • 12. A review of the epidemiology of 1,3-butadiene and chloroprene.
    Acquavella JF; Leonard RC
    Chem Biol Interact; 2001 Jun; 135-136():43-52. PubMed ID: 11397380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Butadiene epidemiology: a summary of results and outstanding issues.
    Acquavella JF
    Toxicology; 1996 Oct; 113(1-3):148-56. PubMed ID: 8901894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemia and cumulative exposure to butadiene, styrene and benzene among workers in the synthetic rubber industry.
    Macaluso M; Larson R; Delzell E; Sathiakumar N; Hovinga M; Julian J; Muir D; Cole P
    Toxicology; 1996 Oct; 113(1-3):190-202. PubMed ID: 8901898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia and exposure to 1,3-butadiene, styrene and dimethyldithiocarbamate among workers in the synthetic rubber industry.
    Delzell E; Macaluso M; Sathiakumar N; Matthews R
    Chem Biol Interact; 2001 Jun; 135-136():515-34. PubMed ID: 11397410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updating IARC's carcinogenicity assessment of benzene.
    Cogliano VJ; Baan R; Straif K;
    Am J Ind Med; 2011 Feb; 54(2):165-7. PubMed ID: 21259300
    [No Abstract]   [Full Text] [Related]  

  • 17. Butadiene epidemiology re-interpreted, again.
    Park RM
    Epidemiology; 1993 Nov; 4(6):559-61. PubMed ID: 8268291
    [No Abstract]   [Full Text] [Related]  

  • 18. Exposure to butadiene and lymphatic and hematopoietic cancer.
    Cole P; Delzell E; Acquavella J
    Epidemiology; 1993 Mar; 4(2):96-103. PubMed ID: 8452913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Individual susceptibility to occupational carcinogens: the evidence from biomonitoring and molecular epidemiology studies].
    Pavanello S; Clonfero E
    G Ital Med Lav Ergon; 2004; 26(4):311-21. PubMed ID: 15584438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic insights from biomarker studies: somatic mutations and rodent/human comparisons following exposure to a potential carcinogen.
    Albertini RJ
    IARC Sci Publ; 2004; (157):153-77. PubMed ID: 15055295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.